Completed Chinese Study Evaluates MRI-AI vs Radiologists for Prostate Cancer Detection — Implications for Australian Practice

References

1. 1.Australian Institute of Health and Welfare. (2023). Cancer in Australia 2023. AIHW. https://doi.org/10.25816/169a-2c23
2. 2.Litwin, M. S., & Tan, H. J. (2017). The diagnosis and treatment of prostate cancer: A review. JAMA, 317(24), 2532-2542. https://doi.org/10.1001/jama.2017.7248
3. 3.Mottet, N., van den Bergh, R. C., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., ... & Cornford, P. (2023). EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. European Urology, 84(1), 1-42. https://doi.org/10.1016/j.eururo.2023.04.016
4. 4.Peking University First Hospital. (2024). Comprehensive evaluation of MRI-AI in prostate cancer diagnosis: A real-world prospective diagnostic study. ClinicalTrials.gov. NCT06575361. https://clinicaltrials.gov/study/NCT06575361
5. 5.Twilt, J. J., van Leeuwen, K. G., Huisman, H. J., Fütterer, J. J., & de Rooij, M. (2021). Artificial intelligence based algorithms for prostate cancer classification and detection on MRI: A narrative review. Diagnostics, 11(6), 959. https://doi.org/10.3390/diagnostics11060959